Description

BSE announces listing of Commercial Paper worth Rs. 75 crore issued by Nuvama Wealth Management Limited on private placement basis, with redemption date of March 2, 2026.

Summary

BSE has listed new Commercial Paper securities issued by Nuvama Wealth Management Limited on private placement basis. The issue consists of 1,500 units of Rs. 5,00,000 each (total Rs. 75 crore) with maturity of 88 days. The securities are rated CARE A1+ and CRISIL A1+ and will trade on BSE Debt segment under scrip code 730697.

Key Points

  • Issuer: Nuvama Wealth Management Limited
  • Instrument: Commercial Paper (Private Placement)
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,91,061.50 per unit
  • Quantity: 1,500 units (Total: Rs. 75 crore)
  • Scrip Code: 730697
  • Scrip ID: NWML31225
  • ISIN: INE531F14FL4 (Further listing under same ISIN)
  • Credit Rating: CARE A1+, CRISIL A1+
  • Market Lot: 1 unit
  • Trading Mode: Dematerialized form only
  • Standard Denomination: Rs. 5 lakhs and multiples thereof
  • Tick Size: 1 paise
  • Issuing and Paying Agent: ICICI Bank Ltd

Regulatory Changes

No regulatory changes introduced. This is a routine listing notification for debt securities.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under the specified ISIN
  • Trading must be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • Members should contact BSE debt department (22728352/8597/8995/5753/8915) for any clarifications

Important Dates

  • Allotment Date: December 4, 2025
  • Listing Date: December 5, 2025
  • Redemption Date: March 2, 2026

Impact Assessment

This is a routine debt market listing with minimal market impact. The commercial paper is an institutional instrument with high minimum denomination (Rs. 5 lakhs), limiting participation to institutional and high net worth investors. The short tenure (88 days) and high credit ratings (A1+ from both CARE and CRISIL) indicate low risk. No impact on equity markets or retail investor segments.

Impact Justification

Routine commercial paper listing announcement for institutional debt instrument with no impact on equity markets or retail investors